Assisted Reproductive Technology (ART) Market: By technology (In-Vitro Fertilization, Artificial Insemination, Surrogacy, Others),By Procedure (Fresh Non donor,Fresh Donor,Frozen Non Donor,Frozen Donor,Embryo Banking), End Users (Hospitals,Fertility Clinics,Others),and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2016-2020 and Forecast 2021-2027


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

The global assisted reproductive technology (ART) market is expected to grow at a CAGR of 7.7% during the forecast period 2021 to 2027. Assisted Reproductive Technology (ART) is a treatment for infertility, performed to achieve the childbirth. ART procedures include stimulation of ovaries to increase the egg production or artificial insemination or combining the sperms and eggs in the laboratory (in vitro) and embryo is transferred to woman to attain the pregnancy.  Asia Pacific assisted reproductive technology (ART) market expected to account for significant share due to rise in infertility cases, late family planning, and availability of technologically advanced fertility services in the region. Latin America assisted reproductive technology market has a notable share in global market owing to expansion of business by the companies, rise in awareness about infertility treatment, and rise in healthcare expenditure are bolster the market. Middle East and Africa assisted reproductive technology market is poised to grow over forecast period owing to economic growth in the Middle East countries and increase in the infertility due to malnutrition in women are expected to upsurge the revenue of market. Obesity and the adoption of bad dietary habits, such as drinking alcohol and smoking, play a significant role in infertility. According to the American Pregnancy Association, infertility affects 30% of men and accounts for about one-fifth of all infertility cases. According to the Centers for Disease Control and Prevention (CDC), 12.1 percent of women between the ages of 15 and 44 are unable to conceive. As a result, an increase in the prevalence of infertility around the world will be a major driving force behind the use of assisted reproductive technologies.

Assisted Reproductive Technology Art Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market


Increase in the number of infertility cases, government initiations to address the infertility incidences, high disposable income in developed countries, increase in population with obesity and mental stress due to change in lifestyle, and rise in consumption of tobacco and alcohol are anticipated to propel the assisted reproductive technology (ART) market over the forecast years. However, high risk of birth defects, high cost of treatment, dearth of skilled professional in underdeveloped countries, and ethical issues may hamper the growth of assisted reproductive technology (ART) market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Assisted Reproductive Technology Art Market Segmentation

  • In-Vitro Fertilization
    • Preimplantation Genetic Diagnosis
    • Intra-cytoplasmic Sperm injection
  • Artificial Insemination
    • Intracervical Insemination
    • Intrauterine Insemination
    • Others
  • Surrogacy
  • Others
  • Fresh Non donor
  • Fresh Donor
  • Frozen Non Donor
  • Frozen Donor
  • Embryo Banking
End User
  • Hospitals
  • Fertility Clinics
  • Others


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Irvin Scientific (U.S.)
  • Origio A/S (Denmark)
  • Microm UK Ltd (U.K.)
  • Parallabs Ltd (U.K.)
  • Cryolab Ltd. (U.K.)
  • Merck KGaA (Germany)
  • Vitrolife AB (Sweden)